Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Muddana, Nageswara Rao
30  Ergebnisse:
Personensuche X
?
1

First-in-Human Studies to Evaluate the Safety, Tolerability..:

Nirogi, Ramakrishna ; Bhyrapuneni, Gopinadh ; Muddana, Nageswara Rao...
Clinical Drug Investigation.  41 (2021)  5 - p. 469-482 , 2021
Link: https://doi.org/10.1007/..
 
?
2

Samelisant (SUVN-G3031), a potent, selective and orally act..:

Nirogi, Ramakrishna ; Benade, Vijay ; Daripelli, Saivishal...
Psychopharmacology.  238 (2021)  6 - p. 1495-1511 , 2021
Link: https://doi.org/10.1007/..
 
?
3

SUVN‐I6107: A novel muscarinic M1 receptor‐positive alloste..:

Abraham, Renny ; Goura, Venkatesh ; Grandhi, Venkata Ramalingayya...
Alzheimer's & Dementia.  16 (2020)  S5 - p. , 2020
Link: https://doi.org/10.1002/..
 
?
4

Safety, Tolerability, and Pharmacokinetics of SUVN-G3031, a..:

Nirogi, Ramakrishna ; Mudigonda, Koteshwara ; Bhyrapuneni, Gopinadh...
Clinical Drug Investigation.  40 (2020)  7 - p. 603-615 , 2020
Link: https://doi.org/10.1007/..
 
?
5

Absorption, distribution, metabolism, excretion (ADME), dru..:

Nirogi, Ramakrishna ; Bhyrapuneni, Gopinadh ; Muddana, Nageswara Rao...
European Journal of Pharmaceutical Sciences.  152 (2020)  - p. 105425 , 2020
Link: https://doi.org/10.1016/..
 
?
6

P2‐031: SAFETY, TOLERABILITY AND HUMAN PHARMACOKINETICS OF ..:

Bhyrapuneni, Gopinadh ; Goyal, Vinod Kumar ; Pandey, Santosh Kumar...
Alzheimer's & Dementia.  15 (2019)  7S_Part_11 - p. , 2019
Link: https://doi.org/10.1016/..
 
?
7

0053 SUVN-G3031: Safety, Tolerability and Pharmacokinetics ..:

Nirogi, Ramakrishna ; Shinde, Anil ; Mudigonda, Koteshwara...
Sleep.  42 (2019)  Supplement_1 - p. A22-A22 , 2019
Link: https://doi.org/10.1093/..
 
?
8

Safety, Tolerability and Pharmacokinetics of the Serotonin ..:

Nirogi, Ramakrishna ; Mudigonda, Koteshwara ; Bhyrapuneni, Gopinadh...
Clinical Drug Investigation.  38 (2018)  5 - p. 401-415 , 2018
Link: https://doi.org/10.1007/..
 
?
9

[P2–033]: SUVN‐502 + DONEPEZIL + MEMANTINE (TRIPLE COMBINAT..:

Nirogi, Ramakrishna ; Mudigonda, Koteshwara ; Ravulu, Jyothsna...
Alzheimer's & Dementia.  13 (2017)  7S_Part_12 - p. , 2017
Link: https://doi.org/10.1016/..
 
?
10

[P1–079]: SUVN‐I6107: A NOVEL MUSCARINIC M1 RECEPTOR‐POSITI..:

Jayarajan, Pradeep ; Abraham, Renny ; Yathavakilla, Sumanth...
Alzheimer's & Dementia.  13 (2017)  7S_Part_5 - p. , 2017
Link: https://doi.org/10.1016/..
 
?
11

Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as ..:

Nirogi, Ramakrishna ; Mohammed, Abdul Rasheed ; Shinde, Anil K....
European Journal of Medicinal Chemistry.  103 (2015)  - p. 289-301 , 2015
Link: https://doi.org/10.1016/..
 
?
12

P4–305: SUVN‐512: A novel 5‐HT6 receptor antagonist with dr..:

Babu, Medapati Rajesh ; Nirogi, Ramakrishna ; Abraham, Renny...
Alzheimer's & Dementia.  9 (2013)  4S_Part_20 - p. , 2013
Link: https://doi.org/10.1016/..
 
?
13

LC–MS/MS method for the quantification of aldose reductase ..:

Nirogi, Ramakrishna ; Kandikere, Vishwottam ; Ajjala, Devender Reddy..
Journal of Pharmaceutical and Biomedical Analysis.  74 (2013)  - p. 227-234 , 2013
Link: https://doi.org/10.1016/..
 
?
14

1‐[2‐(1‐Cyclobutylpiperidin‐4‐yloxy)‐6,7‐dihydro‐4H‐thiazol..:

Shinde, Anil Karbhari ; Badange, Rajesh Kumar ; Reballi, Veena...
ChemMedChem.  17 (2021)  3 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
15

LC-MS/MS method for the determination of pitolisant: applic..:

Nirogi, Ramakrishna ; Ajjala, Devender Reddy ; Kandikere, Vishwottam...
Biomedical Chromatography.  27 (2013)  11 - p. 1431-1437 , 2013
Link: https://doi.org/10.1002/..
 
1-15